HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EU Animal Testing Labeling Guidelines For Cosmetics To Be Adopted

This article was originally published in The Rose Sheet

Executive Summary

The European Commission, in collaboration with European Union member states, will develop guidelines to ensure that common criteria are applied to animal testing labeling claims, according to the conciliation agreement of the Seventh Amendment to the Cosmetics Directive released Nov. 15

You may also be interested in...



Safety Info For Nano In Cosmetics Is Lacking – European Science Committee

There is a lack of available information on the safety of nanomaterials in cosmetics, and the upcoming ban on animal tests in the EU could put that data farther out of reach, according to the European Commission's Scientific Committee on Consumer Products

Safety Info For Nano In Cosmetics Is Lacking – European Science Committee

There is a lack of available information on the safety of nanomaterials in cosmetics, and the upcoming ban on animal tests in the EU could put that data farther out of reach, according to the European Commission's Scientific Committee on Consumer Products

EU Animal Testing Ban Could Conflict With FDA OTC Requirements – USTR

EU legislation banning the sale of cosmetics tested on animals could conflict with FDA testing requirements for certain products classified as OTC drugs, the United States Trade Representative states in an April 1 report estimating potential trade barriers

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS010773

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel